Article
Effects of genetically proxied statins on diabetic nephropathy and retinopathy: a Mendelian randomization study.
Scientific reports - 23 Jul 2024
Zhao Ran, Wang WeiLi, Zhang Wen, Lu JiaPeng, Liu Yi, Guo Jing, Yang Lu, Zhang ZeDan, He Chang, Gu XinYi, Wang Bin
Abstract excerpt
There is no reliable causal evidence for the effect of statins on diabetic nephropathy (DN) and diabetic retinopathy (DR), and the results of previous observational studies are contradictory. Genetic variants linked to low-density lipoprotein cholesterol (LDL-C) from a UK biobank genome-wide association study and located within a 100kb window around HMGCR were used to proxy statins, comparing with PCSK9...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
